297 related articles for article (PubMed ID: 26937968)
1. Oral Bisphosphonates and Upper Gastrointestinal Cancer Risks in Asians with Osteoporosis: A Nested Case-Control Study Using National Retrospective Cohort Sample Data from Korea.
Jung SY; Sohn HS; Park EJ; Suh HS; Park JW; Kwon JW
PLoS One; 2016; 11(3):e0150531. PubMed ID: 26937968
[TBL] [Abstract][Full Text] [Related]
2. A Large National Cohort Study of the Association between Bisphosphonates and Osteonecrosis of the Jaw in Patients with Osteoporosis: A Nested Case-control Study.
Kwon JW; Park EJ; Jung SY; Sohn HS; Ryu H; Suh HS
J Dent Res; 2015 Sep; 94(9 Suppl):212S-9S. PubMed ID: 26001708
[TBL] [Abstract][Full Text] [Related]
3. Oral bisphosphonates and upper gastrointestinal toxicity: a study of cancer and early signals of esophageal injury.
Morden NE; Munson JC; Smith J; Mackenzie TA; Liu SK; Tosteson AN
Osteoporos Int; 2015 Feb; 26(2):663-72. PubMed ID: 25349053
[TBL] [Abstract][Full Text] [Related]
4. Oral Bisphosphonate Exposure and the Risk of Upper Gastrointestinal Cancers.
Vogtmann E; Corley DA; Almers LM; Cardwell CR; Murray LJ; Abnet CC
PLoS One; 2015; 10(10):e0140180. PubMed ID: 26445463
[TBL] [Abstract][Full Text] [Related]
5. Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort.
Green J; Czanner G; Reeves G; Watson J; Wise L; Beral V
BMJ; 2010 Sep; 341():c4444. PubMed ID: 20813820
[TBL] [Abstract][Full Text] [Related]
6. Exposure to oral bisphosphonates and risk of gastrointestinal cancer.
Choi D; Choi S; Chang J; Park SM
Osteoporos Int; 2020 Apr; 31(4):775-782. PubMed ID: 32034451
[TBL] [Abstract][Full Text] [Related]
7. Exposure to oral bisphosphonates and risk of esophageal cancer.
Cardwell CR; Abnet CC; Cantwell MM; Murray LJ
JAMA; 2010 Aug; 304(6):657-63. PubMed ID: 20699457
[TBL] [Abstract][Full Text] [Related]
8. Exposure to bisphosphonates and risk of gastrointestinal cancers: series of nested case-control studies with QResearch and CPRD data.
Vinogradova Y; Coupland C; Hippisley-Cox J
BMJ; 2013 Jan; 346():f114. PubMed ID: 23325866
[TBL] [Abstract][Full Text] [Related]
9. Risk of cardiac valvulopathy with use of bisphosphonates: a population-based, multi-country case-control study.
Coloma PM; de Ridder M; Bezemer I; Herings RM; Gini R; Pecchioli S; Scotti L; Rijnbeek P; Mosseveld M; van der Lei J; Trifirò G; Sturkenboom M;
Osteoporos Int; 2016 May; 27(5):1857-67. PubMed ID: 26694594
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates and risk of upper gastrointestinal cancer--a case control study using the General Practice Research Database (GPRD).
Wright E; Schofield PT; Seed P; Molokhia M
PLoS One; 2012; 7(10):e47616. PubMed ID: 23112825
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonate use and gastrointestinal tract cancer risk: meta-analysis of observational studies.
Oh YH; Yoon C; Park SM
World J Gastroenterol; 2012 Oct; 18(40):5779-88. PubMed ID: 23155320
[TBL] [Abstract][Full Text] [Related]
12. Saving bones without risking brain-bisphosphonates and risk of stroke: matched case-control study.
Asghar ZB; Godoy Caballero A; Pathirannehelage S; Williams J; McKay S; Grassby P; de Lusignan S; Niroshan Siriwardena A
Osteoporos Int; 2019 Sep; 30(9):1845-1854. PubMed ID: 31214750
[TBL] [Abstract][Full Text] [Related]
13. The Association Between Long-Term Bisphosphonate Use and the Risk of Fracture Among Women Aged 50 or Older with Osteoporosis.
Wang CC; Lu HT; Dusetzina SB; Wu CH
J Womens Health (Larchmt); 2016 Jul; 25(7):738-46. PubMed ID: 27096405
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonates and evidence for association with esophageal and gastric cancer: a systematic review and meta-analysis.
Wright E; Schofield PT; Molokhia M
BMJ Open; 2015 Dec; 5(12):e007133. PubMed ID: 26644118
[TBL] [Abstract][Full Text] [Related]
15. Occurrence of gastrointestinal cancer in users of bisphosphonates and other antiresorptive drugs against osteoporosis.
Vestergaard P
Calcif Tissue Int; 2011 Dec; 89(6):434-41. PubMed ID: 22002678
[TBL] [Abstract][Full Text] [Related]
16. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonate Use and the Risk of Undergoing Total Knee Arthroplasty in Osteoporotic Patients with Osteoarthritis: A Nationwide Cohort Study in Taiwan.
Fu SH; Wang CY; Yang RS; Wu FL; Hsiao FY
J Bone Joint Surg Am; 2017 Jun; 99(11):938-946. PubMed ID: 28590379
[TBL] [Abstract][Full Text] [Related]
18. Bisphosphonates Use and Risk of Subtrochanteric and Diaphyseal Femur Fractures in Korea: Results from the National Claim Registry.
Lee YK; Byun DW; Jung SM; Kwon HY; Kim HY; Kim SH; Kim TY; Jang S; Ha YC
Calcif Tissue Int; 2019 Mar; 104(3):313-319. PubMed ID: 30446771
[TBL] [Abstract][Full Text] [Related]
19. A population-based case-control study: proton pump inhibition and risk of hip fracture by use of bisphosphonate.
Lee J; Youn K; Choi NK; Lee JH; Kang D; Song HJ; Park BJ
J Gastroenterol; 2013 Sep; 48(9):1016-22. PubMed ID: 23307040
[TBL] [Abstract][Full Text] [Related]
20. Risk of atrial fibrillation among bisphosphonate users: a multicenter, population-based, Italian study.
Herrera L; Leal I; Lapi F; Schuemie M; Arcoraci V; Cipriani F; Sessa E; Vaccheri A; Piccinni C; Staniscia T; Vestri A; Di Bari M; Corrao G; Zambon A; Gregori D; Carle F; Sturkenboom M; Mazzaglia G; Trifiro G
Osteoporos Int; 2015 May; 26(5):1499-506. PubMed ID: 25752621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
